Status:
ACTIVE_NOT_RECRUITING
Standardizing the Management of Patients with Coronary Microvascular Dysfunction
Lead Sponsor:
Consorzio Futuro in Ricerca
Collaborating Sponsors:
Università degli Studi di Ferrara
Abbott Medical Devices
Conditions:
Coronary Artery Disease
Microvascular Angina
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The SAMCRO is an all comers, prospective, randomized, multicenter, open-label study with blinded adjudicated evaluation of outcomes (PROBE). The diagnosis of angina in non obstructive coronary artery ...
Detailed Description
The aim of the SAMCRO trial is to determine whether a multidomain lifestyle intervention improves angina status and quality of life in ANOCA patients as compared to current standard of care. Patients...
Eligibility Criteria
Inclusion
- Patient admitted to hospital for chronic coronary syndrome (CCS) with indication for coronary artery angiography
- absence of obstructive coronary artery disease at invasive coronary artery angiography
- Coronary microvascular dysfunction as identified by invasive coronary physiology
Exclusion
- Planned coronary revascularization
- Co-morbidity reducing life expectancy to less than 1 year
- Any factor precluding 1-year follow-up
- Prior Coronary Artery Bypass Graft (CABG) surgery
- Presence of a chronic total occlusion (CTO)
Key Trial Info
Start Date :
October 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 4 2029
Estimated Enrollment :
123 Patients enrolled
Trial Details
Trial ID
NCT06025994
Start Date
October 10 2023
End Date
February 4 2029
Last Update
February 6 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
AOU Ferrara
Ferrara, Ferrara, Italy, 44124
2
AOU di Parma
Parma, Parma, Italy